nodes	percent_of_prediction	percent_of_DWPC	metapath
Repaglinide—PPARG—systemic lupus erythematosus	0.358	0.727	CbGaD
Repaglinide—ALB—systemic lupus erythematosus	0.135	0.273	CbGaD
Repaglinide—SLCO1B1—Mycophenolate mofetil—systemic lupus erythematosus	0.0575	0.149	CbGbCtD
Repaglinide—SLCO1B1—Cyclosporine—systemic lupus erythematosus	0.0436	0.113	CbGbCtD
Repaglinide—ALB—Mycophenolate mofetil—systemic lupus erythematosus	0.0315	0.0818	CbGbCtD
Repaglinide—CYP2C8—Dapsone—systemic lupus erythematosus	0.0281	0.0729	CbGbCtD
Repaglinide—ALB—Prednisone—systemic lupus erythematosus	0.0252	0.0654	CbGbCtD
Repaglinide—CYP2C8—Mycophenolate mofetil—systemic lupus erythematosus	0.0243	0.0632	CbGbCtD
Repaglinide—SLCO1B1—Methotrexate—systemic lupus erythematosus	0.0231	0.0599	CbGbCtD
Repaglinide—CYP2C8—Hydrocortisone—systemic lupus erythematosus	0.0195	0.0507	CbGbCtD
Repaglinide—CYP2C8—Cyclosporine—systemic lupus erythematosus	0.0185	0.0479	CbGbCtD
Repaglinide—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.013	0.0338	CbGbCtD
Repaglinide—ALB—Methotrexate—systemic lupus erythematosus	0.0126	0.0328	CbGbCtD
Repaglinide—CYP2C8—Dexamethasone—systemic lupus erythematosus	0.0122	0.0315	CbGbCtD
Repaglinide—CYP3A4—Dapsone—systemic lupus erythematosus	0.0114	0.0296	CbGbCtD
Repaglinide—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.00987	0.0256	CbGbCtD
Repaglinide—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.00987	0.0256	CbGbCtD
Repaglinide—CYP3A4—Betamethasone—systemic lupus erythematosus	0.00847	0.022	CbGbCtD
Repaglinide—CYP3A4—Prednisolone—systemic lupus erythematosus	0.00836	0.0217	CbGbCtD
Repaglinide—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.00792	0.0206	CbGbCtD
Repaglinide—CYP3A4—Prednisone—systemic lupus erythematosus	0.00789	0.0205	CbGbCtD
Repaglinide—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00748	0.0194	CbGbCtD
Repaglinide—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00493	0.0128	CbGbCtD
Repaglinide—SLCO1B1—blood plasma—systemic lupus erythematosus	0.0016	0.0873	CbGeAlD
Repaglinide—PPARG—endothelium—systemic lupus erythematosus	0.00155	0.0848	CbGeAlD
Repaglinide—PPARG—blood plasma—systemic lupus erythematosus	0.00138	0.0753	CbGeAlD
Repaglinide—CYP3A4—urine—systemic lupus erythematosus	0.00118	0.0644	CbGeAlD
Repaglinide—CYP2C8—blood plasma—systemic lupus erythematosus	0.000908	0.0496	CbGeAlD
Repaglinide—ABCC8—kidney—systemic lupus erythematosus	0.000818	0.0447	CbGeAlD
Repaglinide—KCNJ11—lymphoid tissue—systemic lupus erythematosus	0.000763	0.0417	CbGeAlD
Repaglinide—PPARG—connective tissue—systemic lupus erythematosus	0.000733	0.0401	CbGeAlD
Repaglinide—SLCO1B1—kidney—systemic lupus erythematosus	0.000724	0.0396	CbGeAlD
Repaglinide—KCNJ11—tendon—systemic lupus erythematosus	0.000717	0.0392	CbGeAlD
Repaglinide—PPARG—skin of body—systemic lupus erythematosus	0.000662	0.0362	CbGeAlD
Repaglinide—PPARG—kidney—systemic lupus erythematosus	0.000624	0.0341	CbGeAlD
Repaglinide—CYP3A4—blood plasma—systemic lupus erythematosus	0.000615	0.0336	CbGeAlD
Repaglinide—KCNJ11—nervous system—systemic lupus erythematosus	0.000583	0.0319	CbGeAlD
Repaglinide—KCNJ11—central nervous system—systemic lupus erythematosus	0.000561	0.0307	CbGeAlD
Repaglinide—ABCC8—nervous system—systemic lupus erythematosus	0.000537	0.0293	CbGeAlD
Repaglinide—PPARG—lymphoid tissue—systemic lupus erythematosus	0.000536	0.0293	CbGeAlD
Repaglinide—ABCC8—central nervous system—systemic lupus erythematosus	0.000517	0.0282	CbGeAlD
Repaglinide—PPARG—tendon—systemic lupus erythematosus	0.000504	0.0276	CbGeAlD
Repaglinide—PPARG—bone marrow—systemic lupus erythematosus	0.000488	0.0267	CbGeAlD
Repaglinide—PPARG—lung—systemic lupus erythematosus	0.000442	0.0242	CbGeAlD
Repaglinide—CYP2C8—kidney—systemic lupus erythematosus	0.000412	0.0225	CbGeAlD
Repaglinide—PPARG—nervous system—systemic lupus erythematosus	0.00041	0.0224	CbGeAlD
Repaglinide—PPARG—central nervous system—systemic lupus erythematosus	0.000394	0.0216	CbGeAlD
Repaglinide—PPARG—Transcription factor regulation in adipogenesis—ADIPOQ—systemic lupus erythematosus	0.000336	0.0251	CbGpPWpGaD
Repaglinide—PPARG—Differentiation of white and brown adipocyte   —ADIPOQ—systemic lupus erythematosus	0.000304	0.0226	CbGpPWpGaD
Repaglinide—SLCO1B1—Recycling of bile acids and salts—RXRA—systemic lupus erythematosus	0.000293	0.0218	CbGpPWpGaD
Repaglinide—PPARG—Transcription factor regulation in adipogenesis—RXRA—systemic lupus erythematosus	0.000288	0.0215	CbGpPWpGaD
Repaglinide—CYP3A4—kidney—systemic lupus erythematosus	0.000279	0.0152	CbGeAlD
Repaglinide—SLCO1B1—Drug Induction of Bile Acid Pathway—VDR—systemic lupus erythematosus	0.000253	0.0188	CbGpPWpGaD
Repaglinide—PPARG—RXR and RAR heterodimerization with other nuclear receptor—RXRA—systemic lupus erythematosus	0.000252	0.0188	CbGpPWpGaD
Repaglinide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—systemic lupus erythematosus	0.000246	0.0183	CbGpPWpGaD
Repaglinide—PPARG—Transcription factor regulation in adipogenesis—NR3C1—systemic lupus erythematosus	0.000235	0.0175	CbGpPWpGaD
Repaglinide—PPARG—RXR and RAR heterodimerization with other nuclear receptor—VDR—systemic lupus erythematosus	0.000228	0.017	CbGpPWpGaD
Repaglinide—SLCO1B1—Transport of organic anions—ALB—systemic lupus erythematosus	0.000224	0.0167	CbGpPWpGaD
Repaglinide—Abdominal pain—Azathioprine—systemic lupus erythematosus	0.000202	0.00222	CcSEcCtD
Repaglinide—Leukopenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000199	0.00219	CcSEcCtD
Repaglinide—Immune system disorder—Methylprednisolone—systemic lupus erythematosus	0.000197	0.00218	CcSEcCtD
Repaglinide—Gastrointestinal pain—Leflunomide—systemic lupus erythematosus	0.000197	0.00217	CcSEcCtD
Repaglinide—Hypertension—Cyclosporine—systemic lupus erythematosus	0.000197	0.00217	CcSEcCtD
Repaglinide—Palpitations—Mycophenolate mofetil—systemic lupus erythematosus	0.000196	0.00217	CcSEcCtD
Repaglinide—Arrhythmia—Triamcinolone—systemic lupus erythematosus	0.000196	0.00216	CcSEcCtD
Repaglinide—Arrhythmia—Methylprednisolone—systemic lupus erythematosus	0.000195	0.00215	CcSEcCtD
Repaglinide—Hyperglycaemia—Prednisone—systemic lupus erythematosus	0.000195	0.00215	CcSEcCtD
Repaglinide—Arthralgia—Cyclosporine—systemic lupus erythematosus	0.000194	0.00214	CcSEcCtD
Repaglinide—Chest pain—Cyclosporine—systemic lupus erythematosus	0.000194	0.00214	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—systemic lupus erythematosus	0.000193	0.00212	CcSEcCtD
Repaglinide—Hypertension—Mycophenolate mofetil—systemic lupus erythematosus	0.000192	0.00212	CcSEcCtD
Repaglinide—Visual impairment—Betamethasone—systemic lupus erythematosus	0.000192	0.00211	CcSEcCtD
Repaglinide—Visual impairment—Dexamethasone—systemic lupus erythematosus	0.000192	0.00211	CcSEcCtD
Repaglinide—Urticaria—Leflunomide—systemic lupus erythematosus	0.000191	0.00211	CcSEcCtD
Repaglinide—Erythema—Triamcinolone—systemic lupus erythematosus	0.000191	0.0021	CcSEcCtD
Repaglinide—Abdominal pain—Leflunomide—systemic lupus erythematosus	0.00019	0.0021	CcSEcCtD
Repaglinide—Malnutrition—Methylprednisolone—systemic lupus erythematosus	0.00019	0.0021	CcSEcCtD
Repaglinide—Erythema—Methylprednisolone—systemic lupus erythematosus	0.00019	0.0021	CcSEcCtD
Repaglinide—Acute coronary syndrome—Prednisone—systemic lupus erythematosus	0.00019	0.0021	CcSEcCtD
Repaglinide—Arthralgia—Mycophenolate mofetil—systemic lupus erythematosus	0.000189	0.00209	CcSEcCtD
Repaglinide—Chest pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000189	0.00209	CcSEcCtD
Repaglinide—Myocardial infarction—Prednisone—systemic lupus erythematosus	0.000189	0.00208	CcSEcCtD
Repaglinide—ABCC8—FOXA2 and FOXA3 transcription factor networks—NR3C1—systemic lupus erythematosus	0.000188	0.014	CbGpPWpGaD
Repaglinide—Hypersensitivity—Azathioprine—systemic lupus erythematosus	0.000188	0.00207	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic lupus erythematosus	0.000188	0.00207	CcSEcCtD
Repaglinide—PPARG—Nuclear Receptors—RXRA—systemic lupus erythematosus	0.000186	0.0139	CbGpPWpGaD
Repaglinide—Oedema—Cyclosporine—systemic lupus erythematosus	0.000186	0.00205	CcSEcCtD
Repaglinide—Anaphylactic shock—Cyclosporine—systemic lupus erythematosus	0.000186	0.00205	CcSEcCtD
Repaglinide—Eye disorder—Betamethasone—systemic lupus erythematosus	0.000186	0.00205	CcSEcCtD
Repaglinide—Eye disorder—Dexamethasone—systemic lupus erythematosus	0.000186	0.00205	CcSEcCtD
Repaglinide—Back pain—Triamcinolone—systemic lupus erythematosus	0.000184	0.00203	CcSEcCtD
Repaglinide—PPARG—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.000184	0.0137	CbGpPWpGaD
Repaglinide—CYP3A4—nervous system—systemic lupus erythematosus	0.000183	0.01	CbGeAlD
Repaglinide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—NR3C1—systemic lupus erythematosus	0.000183	0.0136	CbGpPWpGaD
Repaglinide—Thrombocytopenia—Cyclosporine—systemic lupus erythematosus	0.000182	0.00201	CcSEcCtD
Repaglinide—Oedema—Mycophenolate mofetil—systemic lupus erythematosus	0.000181	0.002	CcSEcCtD
Repaglinide—Anaphylactic shock—Mycophenolate mofetil—systemic lupus erythematosus	0.000181	0.002	CcSEcCtD
Repaglinide—Skin disorder—Cyclosporine—systemic lupus erythematosus	0.000181	0.00199	CcSEcCtD
Repaglinide—Hypertension—Prednisolone—systemic lupus erythematosus	0.000179	0.00197	CcSEcCtD
Repaglinide—Thrombocytopenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000178	0.00196	CcSEcCtD
Repaglinide—Arrhythmia—Betamethasone—systemic lupus erythematosus	0.000178	0.00196	CcSEcCtD
Repaglinide—Arrhythmia—Dexamethasone—systemic lupus erythematosus	0.000178	0.00196	CcSEcCtD
Repaglinide—Hypersensitivity—Leflunomide—systemic lupus erythematosus	0.000178	0.00196	CcSEcCtD
Repaglinide—Pancreatitis—Methotrexate—systemic lupus erythematosus	0.000177	0.00195	CcSEcCtD
Repaglinide—Skin disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000176	0.00194	CcSEcCtD
Repaglinide—CYP3A4—central nervous system—systemic lupus erythematosus	0.000176	0.00963	CbGeAlD
Repaglinide—Alopecia—Dexamethasone—systemic lupus erythematosus	0.000176	0.00194	CcSEcCtD
Repaglinide—Alopecia—Betamethasone—systemic lupus erythematosus	0.000176	0.00194	CcSEcCtD
Repaglinide—Hypertension—Hydrocortisone—systemic lupus erythematosus	0.000175	0.00193	CcSEcCtD
Repaglinide—Diarrhoea—Azathioprine—systemic lupus erythematosus	0.000175	0.00193	CcSEcCtD
Repaglinide—Erythema—Betamethasone—systemic lupus erythematosus	0.000173	0.00191	CcSEcCtD
Repaglinide—Erythema—Dexamethasone—systemic lupus erythematosus	0.000173	0.00191	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—systemic lupus erythematosus	0.000171	0.00189	CcSEcCtD
Repaglinide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUNB—systemic lupus erythematosus	0.00017	0.0127	CbGpPWpGaD
Repaglinide—Pruritus—Leflunomide—systemic lupus erythematosus	0.00017	0.00188	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Cyclosporine—systemic lupus erythematosus	0.000169	0.00187	CcSEcCtD
Repaglinide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—systemic lupus erythematosus	0.000169	0.0126	CbGpPWpGaD
Repaglinide—Oedema—Prednisolone—systemic lupus erythematosus	0.000169	0.00187	CcSEcCtD
Repaglinide—Anaphylactic shock—Prednisolone—systemic lupus erythematosus	0.000169	0.00187	CcSEcCtD
Repaglinide—PPARG—Nuclear Receptors—VDR—systemic lupus erythematosus	0.000169	0.0126	CbGpPWpGaD
Repaglinide—ALB—Recycling of bile acids and salts—RXRA—systemic lupus erythematosus	0.000167	0.0125	CbGpPWpGaD
Repaglinide—Paraesthesia—Cyclosporine—systemic lupus erythematosus	0.000167	0.00184	CcSEcCtD
Repaglinide—SLCO1B1—Recycling of bile acids and salts—ALB—systemic lupus erythematosus	0.000166	0.0124	CbGpPWpGaD
Repaglinide—Musculoskeletal discomfort—Mycophenolate mofetil—systemic lupus erythematosus	0.000165	0.00182	CcSEcCtD
Repaglinide—Oedema—Hydrocortisone—systemic lupus erythematosus	0.000165	0.00182	CcSEcCtD
Repaglinide—Anaphylactic shock—Hydrocortisone—systemic lupus erythematosus	0.000165	0.00182	CcSEcCtD
Repaglinide—Diarrhoea—Leflunomide—systemic lupus erythematosus	0.000165	0.00182	CcSEcCtD
Repaglinide—Hypertension—Triamcinolone—systemic lupus erythematosus	0.000165	0.00182	CcSEcCtD
Repaglinide—Hypertension—Methylprednisolone—systemic lupus erythematosus	0.000164	0.00181	CcSEcCtD
Repaglinide—Dyspepsia—Cyclosporine—systemic lupus erythematosus	0.000164	0.00181	CcSEcCtD
Repaglinide—Paraesthesia—Mycophenolate mofetil—systemic lupus erythematosus	0.000163	0.0018	CcSEcCtD
Repaglinide—Vomiting—Azathioprine—systemic lupus erythematosus	0.000162	0.00179	CcSEcCtD
Repaglinide—Arthralgia—Methylprednisolone—systemic lupus erythematosus	0.000162	0.00179	CcSEcCtD
Repaglinide—Eye disorder—Prednisone—systemic lupus erythematosus	0.000162	0.00178	CcSEcCtD
Repaglinide—Rash—Azathioprine—systemic lupus erythematosus	0.000161	0.00177	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—systemic lupus erythematosus	0.000161	0.00177	CcSEcCtD
Repaglinide—Dermatitis—Azathioprine—systemic lupus erythematosus	0.000161	0.00177	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Cyclosporine—systemic lupus erythematosus	0.000161	0.00177	CcSEcCtD
Repaglinide—Skin disorder—Hydrocortisone—systemic lupus erythematosus	0.000161	0.00177	CcSEcCtD
Repaglinide—Headache—Azathioprine—systemic lupus erythematosus	0.00016	0.00176	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Methotrexate—systemic lupus erythematosus	0.00016	0.00176	CcSEcCtD
Repaglinide—Dyspepsia—Mycophenolate mofetil—systemic lupus erythematosus	0.00016	0.00176	CcSEcCtD
Repaglinide—Constipation—Cyclosporine—systemic lupus erythematosus	0.000159	0.00175	CcSEcCtD
Repaglinide—ABCC8—FOXA2 and FOXA3 transcription factor networks—F2—systemic lupus erythematosus	0.000158	0.0118	CbGpPWpGaD
Repaglinide—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000157	0.00173	CcSEcCtD
Repaglinide—Immune system disorder—Prednisone—systemic lupus erythematosus	0.000156	0.00172	CcSEcCtD
Repaglinide—Oedema—Triamcinolone—systemic lupus erythematosus	0.000156	0.00172	CcSEcCtD
Repaglinide—Anaphylactic shock—Triamcinolone—systemic lupus erythematosus	0.000156	0.00172	CcSEcCtD
Repaglinide—Anaphylactic shock—Methylprednisolone—systemic lupus erythematosus	0.000155	0.00171	CcSEcCtD
Repaglinide—Constipation—Mycophenolate mofetil—systemic lupus erythematosus	0.000155	0.00171	CcSEcCtD
Repaglinide—Arrhythmia—Prednisone—systemic lupus erythematosus	0.000155	0.00171	CcSEcCtD
Repaglinide—Vomiting—Leflunomide—systemic lupus erythematosus	0.000153	0.00169	CcSEcCtD
Repaglinide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—F2—systemic lupus erythematosus	0.000153	0.0114	CbGpPWpGaD
Repaglinide—SLCO1B1—Bile acid and bile salt metabolism—RXRA—systemic lupus erythematosus	0.000153	0.0114	CbGpPWpGaD
Repaglinide—Alopecia—Prednisone—systemic lupus erythematosus	0.000153	0.00169	CcSEcCtD
Repaglinide—Hepatobiliary disease—Methotrexate—systemic lupus erythematosus	0.000152	0.00168	CcSEcCtD
Repaglinide—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	0.000152	0.00168	CcSEcCtD
Repaglinide—Paraesthesia—Prednisolone—systemic lupus erythematosus	0.000152	0.00168	CcSEcCtD
Repaglinide—Rash—Leflunomide—systemic lupus erythematosus	0.000152	0.00168	CcSEcCtD
Repaglinide—Dermatitis—Leflunomide—systemic lupus erythematosus	0.000152	0.00167	CcSEcCtD
Repaglinide—PPARG—Nuclear Receptors—NR3C1—systemic lupus erythematosus	0.000152	0.0113	CbGpPWpGaD
Repaglinide—Nausea—Azathioprine—systemic lupus erythematosus	0.000152	0.00167	CcSEcCtD
Repaglinide—Headache—Leflunomide—systemic lupus erythematosus	0.000151	0.00166	CcSEcCtD
Repaglinide—Skin disorder—Methylprednisolone—systemic lupus erythematosus	0.000151	0.00166	CcSEcCtD
Repaglinide—Erythema—Prednisone—systemic lupus erythematosus	0.000151	0.00166	CcSEcCtD
Repaglinide—Malnutrition—Prednisone—systemic lupus erythematosus	0.000151	0.00166	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	0.000151	0.00166	CcSEcCtD
Repaglinide—Hypertension—Betamethasone—systemic lupus erythematosus	0.000149	0.00165	CcSEcCtD
Repaglinide—Hypertension—Dexamethasone—systemic lupus erythematosus	0.000149	0.00165	CcSEcCtD
Repaglinide—Paraesthesia—Hydrocortisone—systemic lupus erythematosus	0.000148	0.00164	CcSEcCtD
Repaglinide—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000148	0.00164	CcSEcCtD
Repaglinide—Urticaria—Cyclosporine—systemic lupus erythematosus	0.000148	0.00163	CcSEcCtD
Repaglinide—PPARG—Nuclear Receptor transcription pathway—RXRA—systemic lupus erythematosus	0.000147	0.011	CbGpPWpGaD
Repaglinide—Abdominal pain—Cyclosporine—systemic lupus erythematosus	0.000147	0.00162	CcSEcCtD
Repaglinide—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	0.000145	0.0016	CcSEcCtD
Repaglinide—Hepatitis—Methotrexate—systemic lupus erythematosus	0.000145	0.0016	CcSEcCtD
Repaglinide—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	0.000144	0.00159	CcSEcCtD
Repaglinide—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000143	0.00158	CcSEcCtD
Repaglinide—Nausea—Leflunomide—systemic lupus erythematosus	0.000143	0.00158	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000143	0.00157	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	0.000142	0.00156	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	0.000141	0.00156	CcSEcCtD
Repaglinide—Oedema—Betamethasone—systemic lupus erythematosus	0.000141	0.00156	CcSEcCtD
Repaglinide—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	0.000141	0.00156	CcSEcCtD
Repaglinide—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	0.000141	0.00156	CcSEcCtD
Repaglinide—Oedema—Dexamethasone—systemic lupus erythematosus	0.000141	0.00156	CcSEcCtD
Repaglinide—Paraesthesia—Triamcinolone—systemic lupus erythematosus	0.00014	0.00154	CcSEcCtD
Repaglinide—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	0.000139	0.00154	CcSEcCtD
Repaglinide—Visual impairment—Methotrexate—systemic lupus erythematosus	0.000139	0.00154	CcSEcCtD
Repaglinide—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	0.000138	0.00152	CcSEcCtD
Repaglinide—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	0.000138	0.00152	CcSEcCtD
Repaglinide—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.000137	0.00151	CcSEcCtD
Repaglinide—Dyspepsia—Triamcinolone—systemic lupus erythematosus	0.000137	0.00151	CcSEcCtD
Repaglinide—Erythema multiforme—Methotrexate—systemic lupus erythematosus	0.000137	0.00151	CcSEcCtD
Repaglinide—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	0.000137	0.00151	CcSEcCtD
Repaglinide—Eye disorder—Methotrexate—systemic lupus erythematosus	0.000135	0.00149	CcSEcCtD
Repaglinide—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	0.000135	0.00149	CcSEcCtD
Repaglinide—Urticaria—Prednisolone—systemic lupus erythematosus	0.000134	0.00148	CcSEcCtD
Repaglinide—Cardiac disorder—Methotrexate—systemic lupus erythematosus	0.000134	0.00148	CcSEcCtD
Repaglinide—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.000134	0.00147	CcSEcCtD
Repaglinide—PPARG—Nuclear Receptor transcription pathway—VDR—systemic lupus erythematosus	0.000133	0.00993	CbGpPWpGaD
Repaglinide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—systemic lupus erythematosus	0.000132	0.00981	CbGpPWpGaD
Repaglinide—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000132	0.00145	CcSEcCtD
Repaglinide—CYP3A4—Liver X Receptor Pathway—RXRA—systemic lupus erythematosus	0.000131	0.0098	CbGpPWpGaD
Repaglinide—Urticaria—Hydrocortisone—systemic lupus erythematosus	0.000131	0.00145	CcSEcCtD
Repaglinide—ABCC8—FOXA2 and FOXA3 transcription factor networks—ALB—systemic lupus erythematosus	0.000131	0.00977	CbGpPWpGaD
Repaglinide—KCNJ11—Type II diabetes mellitus—TNF—systemic lupus erythematosus	0.000131	0.00975	CbGpPWpGaD
Repaglinide—Immune system disorder—Methotrexate—systemic lupus erythematosus	0.000131	0.00144	CcSEcCtD
Repaglinide—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	0.000131	0.00144	CcSEcCtD
Repaglinide—Hypertension—Prednisone—systemic lupus erythematosus	0.00013	0.00143	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	0.000129	0.00142	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	0.000129	0.00142	CcSEcCtD
Repaglinide—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.000128	0.00142	CcSEcCtD
Repaglinide—Arthralgia—Prednisone—systemic lupus erythematosus	0.000128	0.00141	CcSEcCtD
Repaglinide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—systemic lupus erythematosus	0.000128	0.00955	CbGpPWpGaD
Repaglinide—Alopecia—Methotrexate—systemic lupus erythematosus	0.000128	0.00141	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	0.000127	0.0014	CcSEcCtD
Repaglinide—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000127	0.0014	CcSEcCtD
Repaglinide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—ALB—systemic lupus erythematosus	0.000127	0.00948	CbGpPWpGaD
Repaglinide—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	0.000127	0.0014	CcSEcCtD
Repaglinide—Paraesthesia—Betamethasone—systemic lupus erythematosus	0.000127	0.0014	CcSEcCtD
Repaglinide—Paraesthesia—Dexamethasone—systemic lupus erythematosus	0.000127	0.0014	CcSEcCtD
Repaglinide—Erythema—Methotrexate—systemic lupus erythematosus	0.000126	0.00139	CcSEcCtD
Repaglinide—Malnutrition—Methotrexate—systemic lupus erythematosus	0.000126	0.00139	CcSEcCtD
Repaglinide—Hypersensitivity—Prednisolone—systemic lupus erythematosus	0.000125	0.00137	CcSEcCtD
Repaglinide—Dyspepsia—Betamethasone—systemic lupus erythematosus	0.000124	0.00137	CcSEcCtD
Repaglinide—Dyspepsia—Dexamethasone—systemic lupus erythematosus	0.000124	0.00137	CcSEcCtD
Repaglinide—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000124	0.00137	CcSEcCtD
Repaglinide—Urticaria—Triamcinolone—systemic lupus erythematosus	0.000124	0.00136	CcSEcCtD
Repaglinide—SLCO1B1—SLC-mediated transmembrane transport—SLC15A4—systemic lupus erythematosus	0.000124	0.00922	CbGpPWpGaD
Repaglinide—PPARG—Transcriptional regulation of white adipocyte differentiation—ADIPOQ—systemic lupus erythematosus	0.000123	0.0092	CbGpPWpGaD
Repaglinide—Urticaria—Methylprednisolone—systemic lupus erythematosus	0.000123	0.00136	CcSEcCtD
Repaglinide—Anaphylactic shock—Prednisone—systemic lupus erythematosus	0.000123	0.00136	CcSEcCtD
Repaglinide—Oedema—Prednisone—systemic lupus erythematosus	0.000123	0.00136	CcSEcCtD
Repaglinide—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	0.000123	0.00135	CcSEcCtD
Repaglinide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—systemic lupus erythematosus	0.000122	0.00912	CbGpPWpGaD
Repaglinide—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.000122	0.00134	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.000122	0.00134	CcSEcCtD
Repaglinide—Back pain—Methotrexate—systemic lupus erythematosus	0.000122	0.00134	CcSEcCtD
Repaglinide—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	0.000122	0.00134	CcSEcCtD
Repaglinide—PPARG—Nuclear Receptor transcription pathway—NR3C1—systemic lupus erythematosus	0.00012	0.00894	CbGpPWpGaD
Repaglinide—Skin disorder—Prednisone—systemic lupus erythematosus	0.000119	0.00132	CcSEcCtD
Repaglinide—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000118	0.0013	CcSEcCtD
Repaglinide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—systemic lupus erythematosus	0.000117	0.00875	CbGpPWpGaD
Repaglinide—Rash—Cyclosporine—systemic lupus erythematosus	0.000117	0.00129	CcSEcCtD
Repaglinide—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000117	0.00129	CcSEcCtD
Repaglinide—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000117	0.00129	CcSEcCtD
Repaglinide—Headache—Cyclosporine—systemic lupus erythematosus	0.000116	0.00128	CcSEcCtD
Repaglinide—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	0.000115	0.00127	CcSEcCtD
Repaglinide—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	0.000115	0.00127	CcSEcCtD
Repaglinide—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000115	0.00127	CcSEcCtD
Repaglinide—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	0.000115	0.00126	CcSEcCtD
Repaglinide—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	0.000114	0.00126	CcSEcCtD
Repaglinide—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.000114	0.00126	CcSEcCtD
Repaglinide—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000114	0.00126	CcSEcCtD
Repaglinide—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000114	0.00125	CcSEcCtD
Repaglinide—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000113	0.00125	CcSEcCtD
Repaglinide—Leukopenia—Methotrexate—systemic lupus erythematosus	0.000113	0.00124	CcSEcCtD
Repaglinide—Urticaria—Dexamethasone—systemic lupus erythematosus	0.000112	0.00124	CcSEcCtD
Repaglinide—Urticaria—Betamethasone—systemic lupus erythematosus	0.000112	0.00124	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	0.000112	0.00124	CcSEcCtD
Repaglinide—Abdominal pain—Dexamethasone—systemic lupus erythematosus	0.000112	0.00123	CcSEcCtD
Repaglinide—Abdominal pain—Betamethasone—systemic lupus erythematosus	0.000112	0.00123	CcSEcCtD
Repaglinide—ABCC8—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	0.000111	0.0083	CbGpPWpGaD
Repaglinide—Nausea—Cyclosporine—systemic lupus erythematosus	0.00011	0.00122	CcSEcCtD
Repaglinide—Paraesthesia—Prednisone—systemic lupus erythematosus	0.00011	0.00122	CcSEcCtD
Repaglinide—Pruritus—Triamcinolone—systemic lupus erythematosus	0.00011	0.00121	CcSEcCtD
Repaglinide—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.00011	0.00121	CcSEcCtD
Repaglinide—Dyspepsia—Prednisone—systemic lupus erythematosus	0.000108	0.00119	CcSEcCtD
Repaglinide—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000108	0.00119	CcSEcCtD
Repaglinide—Chest pain—Methotrexate—systemic lupus erythematosus	0.000107	0.00118	CcSEcCtD
Repaglinide—Arthralgia—Methotrexate—systemic lupus erythematosus	0.000107	0.00118	CcSEcCtD
Repaglinide—Rash—Prednisolone—systemic lupus erythematosus	0.000107	0.00118	CcSEcCtD
Repaglinide—Dermatitis—Prednisolone—systemic lupus erythematosus	0.000107	0.00118	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	0.000106	0.00117	CcSEcCtD
Repaglinide—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.000106	0.00117	CcSEcCtD
Repaglinide—Headache—Prednisolone—systemic lupus erythematosus	0.000106	0.00117	CcSEcCtD
Repaglinide—PPARG—Transcriptional regulation of white adipocyte differentiation—RXRA—systemic lupus erythematosus	0.000106	0.00789	CbGpPWpGaD
Repaglinide—Constipation—Prednisone—systemic lupus erythematosus	0.000105	0.00116	CcSEcCtD
Repaglinide—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.000105	0.00116	CcSEcCtD
Repaglinide—Rash—Hydrocortisone—systemic lupus erythematosus	0.000104	0.00115	CcSEcCtD
Repaglinide—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.000104	0.00115	CcSEcCtD
Repaglinide—Headache—Hydrocortisone—systemic lupus erythematosus	0.000104	0.00114	CcSEcCtD
Repaglinide—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	0.000103	0.00113	CcSEcCtD
Repaglinide—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	0.000101	0.00111	CcSEcCtD
Repaglinide—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	0.000101	0.00111	CcSEcCtD
Repaglinide—Nausea—Prednisolone—systemic lupus erythematosus	0.000101	0.00111	CcSEcCtD
Repaglinide—Pruritus—Dexamethasone—systemic lupus erythematosus	9.99e-05	0.0011	CcSEcCtD
Repaglinide—Pruritus—Betamethasone—systemic lupus erythematosus	9.99e-05	0.0011	CcSEcCtD
Repaglinide—Skin disorder—Methotrexate—systemic lupus erythematosus	9.98e-05	0.0011	CcSEcCtD
Repaglinide—Vomiting—Triamcinolone—systemic lupus erythematosus	9.89e-05	0.00109	CcSEcCtD
Repaglinide—Vomiting—Methylprednisolone—systemic lupus erythematosus	9.87e-05	0.00109	CcSEcCtD
Repaglinide—Nausea—Hydrocortisone—systemic lupus erythematosus	9.82e-05	0.00108	CcSEcCtD
Repaglinide—Rash—Triamcinolone—systemic lupus erythematosus	9.81e-05	0.00108	CcSEcCtD
Repaglinide—Dermatitis—Triamcinolone—systemic lupus erythematosus	9.8e-05	0.00108	CcSEcCtD
Repaglinide—Rash—Methylprednisolone—systemic lupus erythematosus	9.79e-05	0.00108	CcSEcCtD
Repaglinide—Dermatitis—Methylprednisolone—systemic lupus erythematosus	9.78e-05	0.00108	CcSEcCtD
Repaglinide—Urticaria—Prednisone—systemic lupus erythematosus	9.77e-05	0.00108	CcSEcCtD
Repaglinide—Headache—Triamcinolone—systemic lupus erythematosus	9.75e-05	0.00108	CcSEcCtD
Repaglinide—Headache—Methylprednisolone—systemic lupus erythematosus	9.73e-05	0.00107	CcSEcCtD
Repaglinide—Abdominal pain—Prednisone—systemic lupus erythematosus	9.72e-05	0.00107	CcSEcCtD
Repaglinide—PPARG—Transcription factor regulation in adipogenesis—TNF—systemic lupus erythematosus	9.66e-05	0.0072	CbGpPWpGaD
Repaglinide—Diarrhoea—Dexamethasone—systemic lupus erythematosus	9.66e-05	0.00107	CcSEcCtD
Repaglinide—Diarrhoea—Betamethasone—systemic lupus erythematosus	9.66e-05	0.00107	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	9.36e-05	0.00103	CcSEcCtD
Repaglinide—Nausea—Triamcinolone—systemic lupus erythematosus	9.24e-05	0.00102	CcSEcCtD
Repaglinide—Paraesthesia—Methotrexate—systemic lupus erythematosus	9.23e-05	0.00102	CcSEcCtD
Repaglinide—Nausea—Methylprednisolone—systemic lupus erythematosus	9.22e-05	0.00102	CcSEcCtD
Repaglinide—Hypersensitivity—Prednisone—systemic lupus erythematosus	9.06e-05	0.000999	CcSEcCtD
Repaglinide—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—systemic lupus erythematosus	9.05e-05	0.00675	CbGpPWpGaD
Repaglinide—Dyspepsia—Methotrexate—systemic lupus erythematosus	9.05e-05	0.000998	CcSEcCtD
Repaglinide—Vomiting—Dexamethasone—systemic lupus erythematosus	8.98e-05	0.00099	CcSEcCtD
Repaglinide—Vomiting—Betamethasone—systemic lupus erythematosus	8.98e-05	0.00099	CcSEcCtD
Repaglinide—Rash—Betamethasone—systemic lupus erythematosus	8.9e-05	0.000982	CcSEcCtD
Repaglinide—Rash—Dexamethasone—systemic lupus erythematosus	8.9e-05	0.000982	CcSEcCtD
Repaglinide—Dermatitis—Betamethasone—systemic lupus erythematosus	8.89e-05	0.000981	CcSEcCtD
Repaglinide—Dermatitis—Dexamethasone—systemic lupus erythematosus	8.89e-05	0.000981	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	8.87e-05	0.000978	CcSEcCtD
Repaglinide—Headache—Betamethasone—systemic lupus erythematosus	8.85e-05	0.000976	CcSEcCtD
Repaglinide—Headache—Dexamethasone—systemic lupus erythematosus	8.85e-05	0.000976	CcSEcCtD
Repaglinide—ALB—Bile acid and bile salt metabolism—RXRA—systemic lupus erythematosus	8.74e-05	0.00652	CbGpPWpGaD
Repaglinide—Pruritus—Prednisone—systemic lupus erythematosus	8.7e-05	0.000959	CcSEcCtD
Repaglinide—SLCO1B1—Bile acid and bile salt metabolism—ALB—systemic lupus erythematosus	8.69e-05	0.00648	CbGpPWpGaD
Repaglinide—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—systemic lupus erythematosus	8.45e-05	0.0063	CbGpPWpGaD
Repaglinide—PPARG—Adipogenesis—GADD45A—systemic lupus erythematosus	8.42e-05	0.00628	CbGpPWpGaD
Repaglinide—Diarrhoea—Prednisone—systemic lupus erythematosus	8.41e-05	0.000928	CcSEcCtD
Repaglinide—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	8.4e-05	0.000927	CcSEcCtD
Repaglinide—Nausea—Dexamethasone—systemic lupus erythematosus	8.39e-05	0.000925	CcSEcCtD
Repaglinide—Nausea—Betamethasone—systemic lupus erythematosus	8.39e-05	0.000925	CcSEcCtD
Repaglinide—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—systemic lupus erythematosus	8.32e-05	0.0062	CbGpPWpGaD
Repaglinide—ALB—Platelet degranulation—CLU—systemic lupus erythematosus	8.23e-05	0.00614	CbGpPWpGaD
Repaglinide—Urticaria—Methotrexate—systemic lupus erythematosus	8.16e-05	0.0009	CcSEcCtD
Repaglinide—Abdominal pain—Methotrexate—systemic lupus erythematosus	8.12e-05	0.000896	CcSEcCtD
Repaglinide—PPARG—Adipogenesis—ADIPOQ—systemic lupus erythematosus	8.12e-05	0.00605	CbGpPWpGaD
Repaglinide—PPARG—PPARA activates gene expression—RXRA—systemic lupus erythematosus	7.95e-05	0.00593	CbGpPWpGaD
Repaglinide—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—systemic lupus erythematosus	7.87e-05	0.00587	CbGpPWpGaD
Repaglinide—ALB—Response to elevated platelet cytosolic Ca2+—CLU—systemic lupus erythematosus	7.84e-05	0.00585	CbGpPWpGaD
Repaglinide—Vomiting—Prednisone—systemic lupus erythematosus	7.82e-05	0.000862	CcSEcCtD
Repaglinide—PPARG—Transcription factor regulation in adipogenesis—IL6—systemic lupus erythematosus	7.8e-05	0.00581	CbGpPWpGaD
Repaglinide—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—systemic lupus erythematosus	7.79e-05	0.00581	CbGpPWpGaD
Repaglinide—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—RXRA—systemic lupus erythematosus	7.78e-05	0.0058	CbGpPWpGaD
Repaglinide—Rash—Prednisone—systemic lupus erythematosus	7.75e-05	0.000855	CcSEcCtD
Repaglinide—Dermatitis—Prednisone—systemic lupus erythematosus	7.75e-05	0.000854	CcSEcCtD
Repaglinide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—systemic lupus erythematosus	7.74e-05	0.00577	CbGpPWpGaD
Repaglinide—Headache—Prednisone—systemic lupus erythematosus	7.7e-05	0.00085	CcSEcCtD
Repaglinide—Hypersensitivity—Methotrexate—systemic lupus erythematosus	7.57e-05	0.000835	CcSEcCtD
Repaglinide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—systemic lupus erythematosus	7.42e-05	0.00553	CbGpPWpGaD
Repaglinide—Nausea—Prednisone—systemic lupus erythematosus	7.3e-05	0.000806	CcSEcCtD
Repaglinide—Pruritus—Methotrexate—systemic lupus erythematosus	7.27e-05	0.000802	CcSEcCtD
Repaglinide—ALB—SLC-mediated transmembrane transport—SLC15A4—systemic lupus erythematosus	7.06e-05	0.00527	CbGpPWpGaD
Repaglinide—Diarrhoea—Methotrexate—systemic lupus erythematosus	7.03e-05	0.000775	CcSEcCtD
Repaglinide—PPARG—Adipogenesis—RXRA—systemic lupus erythematosus	6.96e-05	0.00519	CbGpPWpGaD
Repaglinide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—systemic lupus erythematosus	6.88e-05	0.00513	CbGpPWpGaD
Repaglinide—Vomiting—Methotrexate—systemic lupus erythematosus	6.53e-05	0.000721	CcSEcCtD
Repaglinide—Rash—Methotrexate—systemic lupus erythematosus	6.48e-05	0.000715	CcSEcCtD
Repaglinide—Dermatitis—Methotrexate—systemic lupus erythematosus	6.47e-05	0.000714	CcSEcCtD
Repaglinide—Headache—Methotrexate—systemic lupus erythematosus	6.44e-05	0.00071	CcSEcCtD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	6.28e-05	0.00468	CbGpPWpGaD
Repaglinide—Nausea—Methotrexate—systemic lupus erythematosus	6.1e-05	0.000673	CcSEcCtD
Repaglinide—ALB—FOXA2 and FOXA3 transcription factor networks—NR3C1—systemic lupus erythematosus	6.07e-05	0.00453	CbGpPWpGaD
Repaglinide—CYP2C8—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	5.84e-05	0.00436	CbGpPWpGaD
Repaglinide—PPARG—Circadian rythm related genes—ADIPOQ—systemic lupus erythematosus	5.73e-05	0.00427	CbGpPWpGaD
Repaglinide—PPARG—Adipogenesis—NR3C1—systemic lupus erythematosus	5.67e-05	0.00423	CbGpPWpGaD
Repaglinide—PPARG—Regulation of retinoblastoma protein—CDKN1B—systemic lupus erythematosus	5.63e-05	0.0042	CbGpPWpGaD
Repaglinide—PPARG—Adipogenesis—FAS—systemic lupus erythematosus	5.49e-05	0.0041	CbGpPWpGaD
Repaglinide—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—systemic lupus erythematosus	5.36e-05	0.004	CbGpPWpGaD
Repaglinide—PPARG—Regulation of retinoblastoma protein—CDKN1A—systemic lupus erythematosus	5.19e-05	0.00387	CbGpPWpGaD
Repaglinide—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	5.19e-05	0.00387	CbGpPWpGaD
Repaglinide—ALB—FOXA2 and FOXA3 transcription factor networks—F2—systemic lupus erythematosus	5.09e-05	0.00379	CbGpPWpGaD
Repaglinide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—systemic lupus erythematosus	5.01e-05	0.00374	CbGpPWpGaD
Repaglinide—PPARG—Regulation of retinoblastoma protein—EP300—systemic lupus erythematosus	4.94e-05	0.00368	CbGpPWpGaD
Repaglinide—ALB—Vitamin B12 Metabolism—CRP—systemic lupus erythematosus	4.9e-05	0.00365	CbGpPWpGaD
Repaglinide—CYP2C8—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	4.74e-05	0.00353	CbGpPWpGaD
Repaglinide—PPARG—Signaling events mediated by HDAC Class I—EP300—systemic lupus erythematosus	4.72e-05	0.00352	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—IL4—systemic lupus erythematosus	4.61e-05	0.00344	CbGpPWpGaD
Repaglinide—ALB—Vitamin B12 Metabolism—F2—systemic lupus erythematosus	4.52e-05	0.00337	CbGpPWpGaD
Repaglinide—CYP2C8—Biological oxidations—NAT2—systemic lupus erythematosus	4.49e-05	0.00335	CbGpPWpGaD
Repaglinide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	4.47e-05	0.00334	CbGpPWpGaD
Repaglinide—CYP2C8—Metapathway biotransformation—NAT2—systemic lupus erythematosus	4.43e-05	0.0033	CbGpPWpGaD
Repaglinide—PPARG—Transcriptional regulation of white adipocyte differentiation—EP300—systemic lupus erythematosus	4.37e-05	0.00326	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—SNRPD1—systemic lupus erythematosus	4.2e-05	0.00313	CbGpPWpGaD
Repaglinide—ALB—Vitamin B12 Metabolism—CCL2—systemic lupus erythematosus	4.03e-05	0.00301	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—CRP—systemic lupus erythematosus	3.99e-05	0.00297	CbGpPWpGaD
Repaglinide—PPARG—Circadian rythm related genes—FAS—systemic lupus erythematosus	3.88e-05	0.00289	CbGpPWpGaD
Repaglinide—PPARG—Signaling events mediated by HDAC Class I—TNF—systemic lupus erythematosus	3.83e-05	0.00285	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—MTA2—systemic lupus erythematosus	3.8e-05	0.00283	CbGpPWpGaD
Repaglinide—PPARG—Transcriptional regulation of white adipocyte differentiation—TGFB1—systemic lupus erythematosus	3.8e-05	0.00283	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—F2—systemic lupus erythematosus	3.68e-05	0.00274	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—CLU—systemic lupus erythematosus	3.65e-05	0.00272	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	3.59e-05	0.00268	CbGpPWpGaD
Repaglinide—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—systemic lupus erythematosus	3.55e-05	0.00264	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—P2RY12—systemic lupus erythematosus	3.54e-05	0.00264	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—LYN—systemic lupus erythematosus	3.45e-05	0.00258	CbGpPWpGaD
Repaglinide—ALB—Vitamin B12 Metabolism—IFNG—systemic lupus erythematosus	3.43e-05	0.00256	CbGpPWpGaD
Repaglinide—CYP2C8—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	3.36e-05	0.0025	CbGpPWpGaD
Repaglinide—PPARG—PPARA activates gene expression—EP300—systemic lupus erythematosus	3.28e-05	0.00245	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—CCL2—systemic lupus erythematosus	3.28e-05	0.00245	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—CSK—systemic lupus erythematosus	3.25e-05	0.00243	CbGpPWpGaD
Repaglinide—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—systemic lupus erythematosus	3.21e-05	0.0024	CbGpPWpGaD
Repaglinide—ALB—Selenium Micronutrient Network—CRP—systemic lupus erythematosus	3.17e-05	0.00236	CbGpPWpGaD
Repaglinide—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	3.14e-05	0.00234	CbGpPWpGaD
Repaglinide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	3.12e-05	0.00233	CbGpPWpGaD
Repaglinide—PPARG—Adipogenesis—CDKN1A—systemic lupus erythematosus	3.02e-05	0.00225	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—LYN—systemic lupus erythematosus	2.96e-05	0.0022	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—PTPRC—systemic lupus erythematosus	2.96e-05	0.0022	CbGpPWpGaD
Repaglinide—ALB—Selenium Micronutrient Network—F2—systemic lupus erythematosus	2.92e-05	0.00218	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—JUNB—systemic lupus erythematosus	2.9e-05	0.00216	CbGpPWpGaD
Repaglinide—ABCC8—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	2.83e-05	0.00211	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—ADIPOQ—systemic lupus erythematosus	2.79e-05	0.00208	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—IFNG—systemic lupus erythematosus	2.79e-05	0.00208	CbGpPWpGaD
Repaglinide—ALB—Selenium Micronutrient Network—CCL2—systemic lupus erythematosus	2.61e-05	0.00194	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—TNFSF13—systemic lupus erythematosus	2.57e-05	0.00191	CbGpPWpGaD
Repaglinide—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	2.54e-05	0.0019	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—RXRA—systemic lupus erythematosus	2.54e-05	0.00189	CbGpPWpGaD
Repaglinide—CYP2C8—Biological oxidations—RXRA—systemic lupus erythematosus	2.52e-05	0.00188	CbGpPWpGaD
Repaglinide—PPARG—Adipogenesis—TGFB1—systemic lupus erythematosus	2.5e-05	0.00186	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—SNRPB—systemic lupus erythematosus	2.48e-05	0.00185	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—IL2—systemic lupus erythematosus	2.48e-05	0.00185	CbGpPWpGaD
Repaglinide—CYP3A4—Biological oxidations—NAT2—systemic lupus erythematosus	2.41e-05	0.0018	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—RXRA—systemic lupus erythematosus	2.39e-05	0.00178	CbGpPWpGaD
Repaglinide—CYP3A4—Metapathway biotransformation—NAT2—systemic lupus erythematosus	2.38e-05	0.00177	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—NAT2—systemic lupus erythematosus	2.37e-05	0.00176	CbGpPWpGaD
Repaglinide—PPARG—Adipogenesis—TNF—systemic lupus erythematosus	2.33e-05	0.00174	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—VDR—systemic lupus erythematosus	2.3e-05	0.00172	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—NAT2—systemic lupus erythematosus	2.3e-05	0.00171	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—RASGRP1—systemic lupus erythematosus	2.22e-05	0.00165	CbGpPWpGaD
Repaglinide—ALB—Vitamin B12 Metabolism—TNF—systemic lupus erythematosus	2.22e-05	0.00165	CbGpPWpGaD
Repaglinide—ALB—Selenium Micronutrient Network—IFNG—systemic lupus erythematosus	2.22e-05	0.00165	CbGpPWpGaD
Repaglinide—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—systemic lupus erythematosus	2.21e-05	0.00165	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	2.14e-05	0.00159	CbGpPWpGaD
Repaglinide—ALB—Selenium Micronutrient Network—PTGS2—systemic lupus erythematosus	2.12e-05	0.00158	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—ITGAX—systemic lupus erythematosus	2.11e-05	0.00157	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—F3—systemic lupus erythematosus	2.08e-05	0.00155	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	2.07e-05	0.00154	CbGpPWpGaD
Repaglinide—PPARG—Circadian rythm related genes—EP300—systemic lupus erythematosus	2.03e-05	0.00151	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—JAK1—systemic lupus erythematosus	2.01e-05	0.0015	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—HIST2H2AC—systemic lupus erythematosus	2e-05	0.00149	CbGpPWpGaD
Repaglinide—PPARG—Adipogenesis—IL6—systemic lupus erythematosus	1.88e-05	0.0014	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—CLU—systemic lupus erythematosus	1.88e-05	0.0014	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—P2RY12—systemic lupus erythematosus	1.82e-05	0.00136	CbGpPWpGaD
Repaglinide—ALB—Platelet degranulation—VEGFA—systemic lupus erythematosus	1.81e-05	0.00135	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—TNF—systemic lupus erythematosus	1.81e-05	0.00135	CbGpPWpGaD
Repaglinide—ALB—Vitamin B12 Metabolism—IL6—systemic lupus erythematosus	1.79e-05	0.00133	CbGpPWpGaD
Repaglinide—SLCO1B1—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	1.79e-05	0.00133	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—JAK1—systemic lupus erythematosus	1.72e-05	0.00128	CbGpPWpGaD
Repaglinide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—systemic lupus erythematosus	1.72e-05	0.00128	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—NAT2—systemic lupus erythematosus	1.7e-05	0.00126	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.68e-05	0.00125	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—SELE—systemic lupus erythematosus	1.68e-05	0.00125	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—CSK—systemic lupus erythematosus	1.68e-05	0.00125	CbGpPWpGaD
Repaglinide—ALB—Platelet degranulation—TGFB1—systemic lupus erythematosus	1.66e-05	0.00124	CbGpPWpGaD
Repaglinide—ABCC8—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.61e-05	0.0012	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—IL2RA—systemic lupus erythematosus	1.61e-05	0.0012	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	1.6e-05	0.00119	CbGpPWpGaD
Repaglinide—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—systemic lupus erythematosus	1.58e-05	0.00118	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—ITGAM—systemic lupus erythematosus	1.58e-05	0.00118	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—LYN—systemic lupus erythematosus	1.52e-05	0.00114	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—SH2B3—systemic lupus erythematosus	1.5e-05	0.00111	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—IL6—systemic lupus erythematosus	1.46e-05	0.00109	CbGpPWpGaD
Repaglinide—ALB—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	1.43e-05	0.00107	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—F2—systemic lupus erythematosus	1.4e-05	0.00104	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—JUNB—systemic lupus erythematosus	1.4e-05	0.00104	CbGpPWpGaD
Repaglinide—CYP3A4—Biological oxidations—RXRA—systemic lupus erythematosus	1.35e-05	0.00101	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—NAT2—systemic lupus erythematosus	1.34e-05	0.000996	CbGpPWpGaD
Repaglinide—PPARG—Circadian rythm related genes—IL6—systemic lupus erythematosus	1.33e-05	0.00099	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—RXRA—systemic lupus erythematosus	1.33e-05	0.000989	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—TYK2—systemic lupus erythematosus	1.32e-05	0.000986	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—RXRA—systemic lupus erythematosus	1.29e-05	0.000959	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—RXRA—systemic lupus erythematosus	1.22e-05	0.000912	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.21e-05	0.000904	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—IFNA1—systemic lupus erythematosus	1.17e-05	0.000876	CbGpPWpGaD
Repaglinide—ALB—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	1.16e-05	0.000863	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—RASGRP1—systemic lupus erythematosus	1.14e-05	0.000853	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—VDR—systemic lupus erythematosus	1.11e-05	0.000826	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.06e-05	0.000792	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.06e-05	0.000791	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—MMP9—systemic lupus erythematosus	1.04e-05	0.000777	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—NR3C1—systemic lupus erythematosus	9.97e-06	0.000743	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—EP300—systemic lupus erythematosus	9.88e-06	0.000736	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	9.66e-06	0.00072	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	9.61e-06	0.000716	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	9.55e-06	0.000712	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—RXRA—systemic lupus erythematosus	9.51e-06	0.000709	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—IL2—systemic lupus erythematosus	9.42e-06	0.000703	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—VEGFA—systemic lupus erythematosus	9.35e-06	0.000697	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	9.13e-06	0.000681	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	9.08e-06	0.000677	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—JAK1—systemic lupus erythematosus	8.87e-06	0.000662	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	8.82e-06	0.000658	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—TGFB1—systemic lupus erythematosus	8.59e-06	0.00064	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PPARG—systemic lupus erythematosus	8.38e-06	0.000625	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	8.35e-06	0.000623	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—IL2RA—systemic lupus erythematosus	8.29e-06	0.000618	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PPARG—systemic lupus erythematosus	8.12e-06	0.000606	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—TNF—systemic lupus erythematosus	8.02e-06	0.000598	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—VEGFA—systemic lupus erythematosus	8.01e-06	0.000597	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—NAT2—systemic lupus erythematosus	7.68e-06	0.000572	CbGpPWpGaD
Repaglinide—ALB—Metabolism—NAT2—systemic lupus erythematosus	7.63e-06	0.000569	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—ALB—systemic lupus erythematosus	7.53e-06	0.000562	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—RXRA—systemic lupus erythematosus	7.49e-06	0.000558	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—TGFB1—systemic lupus erythematosus	7.35e-06	0.000548	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—ALB—systemic lupus erythematosus	7.3e-06	0.000545	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—F2—systemic lupus erythematosus	7.21e-06	0.000538	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—NOS3—systemic lupus erythematosus	7.21e-06	0.000537	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—NOS3—systemic lupus erythematosus	6.99e-06	0.000521	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	6.95e-06	0.000518	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PTGS2—systemic lupus erythematosus	6.59e-06	0.000491	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—IL6—systemic lupus erythematosus	6.47e-06	0.000482	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PTGS2—systemic lupus erythematosus	6.39e-06	0.000476	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	6.1e-06	0.000455	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	6.07e-06	0.000452	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—NOS3—systemic lupus erythematosus	5.73e-06	0.000427	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	5.49e-06	0.000409	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—EP300—systemic lupus erythematosus	5.48e-06	0.000409	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—ALB—systemic lupus erythematosus	5.4e-06	0.000403	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—EP300—systemic lupus erythematosus	5.32e-06	0.000396	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—NOS3—systemic lupus erythematosus	5.16e-06	0.000385	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—IL2—systemic lupus erythematosus	4.86e-06	0.000362	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	4.8e-06	0.000358	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	4.77e-06	0.000356	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PPARG—systemic lupus erythematosus	4.73e-06	0.000352	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PTGS2—systemic lupus erythematosus	4.72e-06	0.000352	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—EP300—systemic lupus erythematosus	4.36e-06	0.000325	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—RXRA—systemic lupus erythematosus	4.3e-06	0.000321	CbGpPWpGaD
Repaglinide—ALB—Metabolism—RXRA—systemic lupus erythematosus	4.28e-06	0.000319	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—ALB—systemic lupus erythematosus	4.25e-06	0.000317	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—VEGFA—systemic lupus erythematosus	4.13e-06	0.000308	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	4.12e-06	0.000307	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—NOS3—systemic lupus erythematosus	4.07e-06	0.000303	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.99e-06	0.000298	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.97e-06	0.000296	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—EP300—systemic lupus erythematosus	3.93e-06	0.000293	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—TGFB1—systemic lupus erythematosus	3.79e-06	0.000283	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PTGS2—systemic lupus erythematosus	3.72e-06	0.000277	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—EP300—systemic lupus erythematosus	3.09e-06	0.000231	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PPARG—systemic lupus erythematosus	2.72e-06	0.000203	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PPARG—systemic lupus erythematosus	2.7e-06	0.000201	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ALB—systemic lupus erythematosus	2.44e-06	0.000182	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—NOS3—systemic lupus erythematosus	2.34e-06	0.000174	CbGpPWpGaD
Repaglinide—ALB—Metabolism—NOS3—systemic lupus erythematosus	2.32e-06	0.000173	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	2.31e-06	0.000172	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PTGS2—systemic lupus erythematosus	2.14e-06	0.000159	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PTGS2—systemic lupus erythematosus	2.13e-06	0.000158	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—EP300—systemic lupus erythematosus	1.78e-06	0.000133	CbGpPWpGaD
Repaglinide—ALB—Metabolism—EP300—systemic lupus erythematosus	1.77e-06	0.000132	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	1.46e-06	0.000109	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	1.31e-06	9.78e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	1.25e-06	9.35e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	1.15e-06	8.55e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	9.54e-07	7.11e-05	CbGpPWpGaD
